Clinical Trial Update: Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating spironolactone for resistant hypertension in Cameroonian patients with diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Sobngwi Eugene | Conditions: Hypertension, Resistant to Conventional Therapy, Diabetes Mellitus | Phase 4 | Status: COMPLETED